Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amit Saxena

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Autoimmunity Reviews|July 16, 2017
Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNPPeter M Izmirly, Marc K Halushka, Avi Z Rosenberg, et al.
Arthritis Research & Therapy|August 19, 2020
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective studyRuth Fernandez-Ruiz, Nicole Bornkamp, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Cardiovascular Research|April 4, 2017
Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodellingArti V Shinde, Marcin Dobaczewski, Judith J de Haan, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Impact of Phosphodiesterase-5 Inhibitor Treatment Delay on Secondary Raynaud's Phenomenon Outcomes: A Retrospective Cohort StudyIsabella Zappi, Derek Maas, Michelle Sikora, et al.
Arthritis Care & Research|August 30, 2022
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus NephritisCristina Arriens, Y K Onno Teng, Ellen M Ginzler, et al.
Circulation. Arrhythmia and Electrophysiology|September 10, 2020
Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout GestationDeborah M Friedman, Mimi Kim, Nathalie Costedoat-Chalumeau, et al.
Autoimmunity Reviews|September 7, 2013
Letter to the Editor in response to the article "Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials." by Gleicher N, Elkayam U, Autoimmun Rev. 2013 Sep;12(11):1039-45Nathalie Costedoat-Chalumeau, Peter Izmirly, Robert Clancy, et al.
Lupus Science & Medicine|April 17, 2018
Lupus community panel proposals for optimising clinical trials: 2018Joan T Merrill, Susan Manzi, Cynthia Aranow, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Autoimmunity Reviews|July 16, 2017
Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNPPeter M Izmirly, Marc K Halushka, Avi Z Rosenberg, et al.
Arthritis Research & Therapy|August 19, 2020
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective studyRuth Fernandez-Ruiz, Nicole Bornkamp, Mimi Y Kim, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 31, 2019
Complement Activation in Patients With Probable Systemic Lupus Erythematosus and Ability to Predict Progression to American College of Rheumatology-Classified Systemic Lupus ErythematosusRosalind Ramsey-Goldman, Roberta Vezza Alexander, Elena M Massarotti, et al.
ACR Open Rheumatology|February 4, 2021
A Multianalyte Assay Panel With Cell-Bound Complement Activation Products Predicts Transition of Probable Lupus to American College of Rheumatology-Classified LupusRosalind Ramsey-Goldman, Roberta Vezza Alexander, John Conklin, et al.
Cardiovascular Research|April 4, 2017
Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodellingArti V Shinde, Marcin Dobaczewski, Judith J de Haan, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Impact of Phosphodiesterase-5 Inhibitor Treatment Delay on Secondary Raynaud's Phenomenon Outcomes: A Retrospective Cohort StudyIsabella Zappi, Derek Maas, Michelle Sikora, et al.
Arthritis Care & Research|August 30, 2022
Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus NephritisCristina Arriens, Y K Onno Teng, Ellen M Ginzler, et al.
Circulation. Arrhythmia and Electrophysiology|September 10, 2020
Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout GestationDeborah M Friedman, Mimi Kim, Nathalie Costedoat-Chalumeau, et al.
Autoimmunity Reviews|September 7, 2013
Letter to the Editor in response to the article "Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials." by Gleicher N, Elkayam U, Autoimmun Rev. 2013 Sep;12(11):1039-45Nathalie Costedoat-Chalumeau, Peter Izmirly, Robert Clancy, et al.
Lupus Science & Medicine|April 17, 2018
Lupus community panel proposals for optimising clinical trials: 2018Joan T Merrill, Susan Manzi, Cynthia Aranow, et al.
Pageof 15